Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

SARS-CoV-2 growth, furin-cleavage-site adaptation and neutralization using serum from acutely infected hospitalized COVID-19 patients.

The Journal of general virology - 1 Nov 2020

Klimstra William B, Tilston-Lunel Natasha L, Nambulli Sham, Boslett James, McMillen Cynthia M, Gilliland Theron, Dunn Matthew D, Sun Chengun, Wheeler Sarah E, Wells Alan, Hartman Amy L, McElroy Anita K, Reed Douglas S, Rennick Linda J, Duprex W Paul

Abstract excerpt

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), emerged at the end of 2019 and by mid-June 2020 the virus had spread to at least 215 countries, caused more than 8 000 000 confirmed infections and over 450 000 deaths, and overwhelmed healthcare systems worldwide. Like severe acute respiratory syndrome coronavirus (SARS-CoV), which emerged in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Neutralizing
Share to Furin

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hospitalization

Share to Immunoglobulin A

Share to Immunoglobulin G

Share to Neutralization Tests

Share to Proteolysis

Share to Vero Cells

Source

Open in PubMed Open full text

Identifiers

PMID: 32821033
DOI: 10.1099/jgv.0.001481
PMCID: PMC7879561

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

SARS-CoV-2 growth, furin-cleavage-site adaptation and neutralization using serum from acutely infected hospitalized COVID-19 patients.PMID 32821033Read ↗

SARS-CoV-2 growth, furin-cleavage-site adaptation and neutralization using serum from acutely infected, hospitalized COVID-19 patientsSemantic proximity Read ↗

Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis.Semantic proximity Read ↗

Furin Cleavage Site Is Key to SARS-CoV-2 PathogenesisSemantic proximity Read ↗

Rapid SARS-CoV-2 Adaptation to Available Cellular Proteases.Semantic proximity Read ↗

Acquisition of Furin Cleavage Site and Further SARS-CoV-2 Evolution Change the Mechanisms of Viral Entry, Infection Spread, and Cell SignalingSemantic proximity Read ↗

Vero cell-adapted SARS-CoV-2 strain shows increased viral growth through furin-mediated efficient spike cleavageSemantic proximity Read ↗

The role of furin cleavage site in SARS-CoV-2 spike protein-mediated membrane fusion in the presence or absence of trypsinSemantic proximity Read ↗

Natural Polymorphisms Are Present in the Furin Cleavage Site of the SARS-CoV-2 Spike GlycoproteinSemantic proximity Read ↗

SARS-CoV-2 mutations acquired in mink reduce antibody-mediated neutralizationSemantic proximity Read ↗

The Emergence of the Spike Furin Cleavage Site in SARS-CoV-2Semantic proximity Read ↗

SARS-CoV-2 S Mutations: A Lesson from the Viral World to Understand How Human Furin Works.Semantic proximity Read ↗

SARS-CoV-2 bearing a mutation at the S1/S2 cleavage site exhibits attenuated virulence and confers protective immunitySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.